CAS 300809-71-6

4-(benzo[d]thiazol-2-ylthio)-3-chloroaniline

CAS : 300809-71-6

Formule : C₁₃H₉ClN₂S₂

Degré de pureté : 98%

Masse moléculaire : 292.8070

Ref: IN-DA01KJWQ

KRAS inhibitor-9

CAS : 300809-71-6

KRAS inhibitor-9

Degré de pureté : ≥98%

Masse moléculaire : 292.81g/mol

Ref: 54-BUP02567

4-(Benzo[d]thiazol-2-ylthio)-3-chloroaniline

CAS : 300809-71-6

4-(Benzo[d]thiazol-2-ylthio)-3-chloroaniline

Degré de pureté : 98%

Masse moléculaire : 292.81g/mol

Ref: 54-OR1024093

KRAS inhibitor-9

CAS : 300809-71-6

KRAS inhibitor-9 (DUN09716) hinders GTP-KRAS formation, with a Kd of 92 μM, causes G2/M arrest, and induces apoptosis in mutated NSC-LC cells.

Formule : C₁₃H₉ClN₂S₂

Degré de pureté : 99.66%

Couleur et forme : Solid

Masse moléculaire : 292.81

Ref: TM-T8756

Kras inhibitor-9

CAS : 300809-71-6

Kras inhibitor-9 is a research tool that is used in cell biology, pharmacology and ion channels. It has been shown to inhibit the activity of KrasG12D and other GTPase proteins. Kras inhibitor-9 binds to the peptide sequence DQPYFQN near the N terminus of KrasG12D, blocking its interaction with other proteins. This binding prevents KrasG12D from activating downstream signaling pathways, including MAPK/ERK kinases and Akt kinases. Kras inhibitor-9 may be able to inhibit tumor growth by blocking activation of oncogenes such as Kras and p53.

Formule : C₁₃H₉ClN₂S₂

Degré de pureté : Min. 95%

Masse moléculaire : 292.8 g/mol

Ref: 3D-AMA80971